Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2006) | Total Docs. (3years) | Total Refs. (2006) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2006) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 8.345 Q1 | 254 | 37 | 80 | 8836 | 1662 | 77 | 18.65 | 238.81 |  |
| 2 | Pharmacology and Therapeutics | journal | 4.180 Q1 | 233 | 134 | 202 | 30111 | 2026 | 198 | 9.52 | 224.71 | |
| 3 | Annual Review of Pharmacology and Toxicology | journal | 9.892 Q1 | 224 | 17 | 77 | 2900 | 1854 | 77 | 25.96 | 170.59 | |
| 4 | Medicinal Research Reviews | journal | 2.620 Q1 | 150 | 24 | 83 | 4024 | 781 | 83 | 8.69 | 167.67 | |
| 5 | Reviews of Physiology Biochemistry and Pharmacology | journal | 6.223 Q1 | 70 | 8 | 44 | 1340 | 537 | 44 | 8.71 | 167.50 |  |
| 6 | Progress in Medicinal Chemistry | journal | 0.849 Q2 | 38 | 8 | 23 | 1253 | 67 | 20 | 2.60 | 156.63 |  |
| 7 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.719 Q1 | 82 | 13 | 36 | 1808 | 256 | 36 | 6.26 | 139.08 | |
| 8 | Advances in Molecular Toxicology | book series | 18 | 6 | 0 | 761 | 0 | 0 | 0.00 | 126.83 | | |
| 9 | Drug Resistance Updates | journal | 2.412 Q1 | 132 | 19 | 92 | 2342 | 577 | 86 | 6.31 | 123.26 | |
| 10 | Current Drug Metabolism | journal | 1.835 Q1 | 122 | 65 | 123 | 7593 | 861 | 117 | 6.92 | 116.82 | |
| 11 | Expert Opinion on Emerging Drugs | journal | 0.708 Q2 | 54 | 46 | 116 | 5338 | 331 | 116 | 3.06 | 116.04 |  |
| 12 | Toxicological Reviews | journal | 0.695 Q2 | 49 | 20 | 75 | 2097 | 178 | 67 | 1.71 | 104.85 | |
| 13 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.319 Q3 | 100 | 69 | 51 | 6961 | 76 | 51 | 1.49 | 100.88 | |
| 14 | Cellular and Molecular Life Sciences | journal | 2.857 Q1 | 261 | 258 | 782 | 24555 | 4185 | 776 | 5.10 | 95.17 |  |
| 15 | CNS Drug Reviews | journal | 1.246 Q1 | 64 | 19 | 72 | 1749 | 253 | 70 | 2.92 | 92.05 | |
| 16 | Neurotherapeutics | journal | 1.932 Q1 | 136 | 53 | 109 | 4821 | 655 | 98 | 6.01 | 90.96 | |
| 17 | Inflammation and Allergy - Drug Targets | journal | 55 | 32 | 0 | 2799 | 0 | 0 | 0.00 | 87.47 | | |
| 18 | Current Pharmacogenomics | journal | 0.183 Q3 | 12 | 33 | 56 | 2875 | 34 | 56 | 0.61 | 87.12 | |
| 19 | Expert Opinion on Biological Therapy | journal | 0.910 Q2 | 102 | 118 | 426 | 10116 | 1358 | 420 | 3.26 | 85.73 | |
| 20 | Journal of NeuroImmune Pharmacology | journal | 91 | 40 | 0 | 3423 | 0 | 0 | 0.00 | 85.58 | | |
| 21 | Expert Opinion on Therapeutic Targets | journal | 1.268 Q1 | 106 | 84 | 204 | 7122 | 651 | 195 | 3.07 | 84.79 | |
| 22 | Expert Opinion on Investigational Drugs | journal | 1.075 Q1 | 117 | 138 | 426 | 11102 | 1507 | 414 | 3.45 | 80.45 | |
| 23 | Expert Review of Vaccines | journal | 0.810 Q2 | 105 | 76 | 265 | 6009 | 679 | 243 | 2.24 | 79.07 | |
| 24 | Journal of International Peacekeeping | journal | 0.100 Q4 | 14 | 10 | 39 | 790 | 2 | 37 | 0.05 | 79.00 | |
| 25 | Advances in Pharmacology | journal | 0.151 Q4 | 86 | 42 | 54 | 3296 | 24 | 50 | 0.44 | 78.48 | |
| 26 | Cardiovascular Drug Reviews | journal | 0.682 Q2 | 54 | 21 | 73 | 1607 | 159 | 73 | 2.10 | 76.52 | |
| 27 | Core Evidence (discontinued) | journal | 0.102 Q4 | 29 | 8 | 12 | 596 | 0 | 11 | 0.00 | 74.50 |  |
| 28 | Addiction Biology | journal | 0.754 Q2 | 93 | 33 | 132 | 2367 | 259 | 120 | 2.05 | 71.73 | |
| 29 | Expert Opinion on Pharmacotherapy | journal | 0.565 Q2 | 93 | 226 | 676 | 15502 | 1536 | 663 | 2.27 | 68.59 | |
| 30 | Clinical Pharmacokinetics | journal | 1.534 Q1 | 184 | 82 | 241 | 5255 | 1530 | 238 | 5.41 | 64.09 | |
| 31 | Expert Opinion on Therapeutic Patents | journal | 0.456 Q3 | 88 | 117 | 362 | 7106 | 494 | 350 | 1.53 | 60.74 | |
| 32 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.336 Q3 | 56 | 70 | 237 | 4210 | 273 | 236 | 1.19 | 60.14 |  |
| 33 | BioDrugs | journal | 0.786 Q2 | 79 | 42 | 125 | 2488 | 383 | 123 | 3.70 | 59.24 | |
| 34 | Chinese Medicine | journal | 56 | 4 | 0 | 235 | 0 | 0 | 0.00 | 58.75 | | |
| 35 | Current Opinion in Investigational Drugs | journal | 1.120 Q1 | 83 | 132 | 484 | 7673 | 1527 | 446 | 3.01 | 58.13 | |
| 36 | Current Opinion in Drug Discovery and Development | journal | 1.404 Q1 | 85 | 67 | 245 | 3875 | 1246 | 229 | 5.43 | 57.84 | |
| 37 | Neuropsychopharmacology | journal | 2.724 Q1 | 249 | 285 | 762 | 16343 | 4804 | 734 | 6.33 | 57.34 | |
| 38 | Current Opinion in Molecular Therapeutics | journal | 0.908 Q2 | 67 | 69 | 270 | 3935 | 701 | 241 | 2.55 | 57.03 | |
| 39 | Drug Safety | journal | 1.352 Q1 | 140 | 93 | 262 | 5283 | 1202 | 245 | 4.54 | 56.81 | |
| 40 | Molecular Diagnosis and Therapy | journal | 68 | 43 | 186 | 2421 | 548 | 184 | 2.88 | 56.30 | | |
| 41 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.126 Q4 | 40 | 7 | 64 | 387 | 15 | 64 | 0.03 | 55.29 | |
| 42 | Psychopharmacology | journal | 1.892 Q1 | 214 | 366 | 1156 | 19456 | 5043 | 1107 | 4.18 | 53.16 | |
| 43 | Biochemical Pharmacology | journal | 1.533 Q1 | 220 | 319 | 1357 | 16908 | 5632 | 1310 | 4.05 | 53.00 | |
| 44 | Trends in Pharmacological Sciences | journal | 4.402 Q1 | 244 | 104 | 356 | 5460 | 3669 | 324 | 10.55 | 52.50 | |
| 45 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.767 Q2 | 99 | 94 | 386 | 4860 | 1009 | 382 | 3.03 | 51.70 | |
| 46 | Pharmacology Biochemistry and Behavior | journal | 0.929 Q2 | 148 | 257 | 816 | 13069 | 2042 | 813 | 2.40 | 50.85 | |
| 47 | Xenobiotica | journal | 0.512 Q3 | 89 | 71 | 242 | 3596 | 475 | 242 | 1.93 | 50.65 | |
| 48 | Canadian Journal of Physiology and Pharmacology | journal | 0.705 Q2 | 95 | 142 | 410 | 7065 | 691 | 403 | 1.52 | 49.75 |  |
| 49 | Vascular Pharmacology | journal | 0.644 Q2 | 108 | 112 | 155 | 5564 | 296 | 151 | 1.97 | 49.68 | |
| 50 | Apoptosis : an international journal on programmed cell death | journal | 1.761 Q1 | 128 | 192 | 283 | 9438 | 1189 | 281 | 3.73 | 49.16 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data